Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

608
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
608
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

49
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
49
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

65
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
65
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

460
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
460
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.0K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.0K
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

43
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
43

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Race, Ethnicity, and Language Disparities in Alcohol and Drug Screening and Medication Treatment.

JAMA network open·2026
Same author

Contingency Management for the Treatment of Stimulant Use Disorder.

JAMA internal medicine·2026
Same author

Cervical Cancer Screening among Older Latina Migrant and Seasonal Farmworkers in a Network of Community Health Centers.

Ethnicity & disease·2026
Same author

Polymer solutions under steady solvent flow between two semipermeable interfaces.

Macromolecules·2026
Same author

Early health technology assessment of a primary care tool for the diagnosis and management of headaches in Alberta, Canada.

International journal of technology assessment in health care·2026
Same author

Rural community peer partnerships for improving methamphetamine -associated heart failure screening and engagement in cardiology care (PEER-Heart): Study protocol.

Drug and alcohol dependence reports·2026

Related Experiment Video

Updated: Nov 4, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.5K

Interim methadone - Effective but underutilized: A scoping review.

Dennis McCarty1, Brian Chan2, Christina Bougatsos3

  • 1Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, BICC, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, United States; OHSU-PSU School of Public Health, Oregon Health & Science University, CB669, United States.

Drug and Alcohol Dependence
|May 29, 2021
PubMed
Summary

Interim methadone services, offering up to 120 days of dosing without counseling, effectively reduce opioid use and increase access to treatment programs. Alternative strategies also show promise in minimizing wait times for essential medication-assisted treatment.

Keywords:
Interim methadoneMethadoneOpioid use disorder

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.9K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.4K

Related Experiment Videos

Last Updated: Nov 4, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.5K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.9K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.4K

Area of Science:

  • Addiction Medicine
  • Public Health
  • Pharmacotherapy

Background:

  • Opioid Treatment Programs (OTPs) face challenges with long wait lists for medication-assisted treatment.
  • Interim methadone services, providing short-term methadone dosing without mandatory counseling, are a potential strategy to mitigate these delays.
  • Regulatory constraints influence the implementation and accessibility of interim methadone services.

Purpose of the Study:

  • To summarize existing evidence on the efficacy and safety of interim methadone services.
  • To explore alternative strategies for reducing wait times and improving access to methadone treatment.
  • To evaluate the impact of these interventions on patient outcomes, including substance use and treatment retention.

Main Methods:

  • A scoping review methodology was employed to identify relevant studies.
  • Prioritization was given to randomized trials and controlled observational studies, with inclusion of lower-quality evidence where necessary.
  • Studies examined interim methadone, low-threshold services, open access policies, and medication-first approaches.

Main Results:

  • Six studies focused on interim methadone, demonstrating reductions in heroin use and higher likelihood of entering formal OTPs compared to waitlist controls.
  • Retention rates in interim methadone services were comparable to those in standard, active treatment.
  • Alternative strategies, such as low-threshold services, also proved effective in facilitating access to methadone treatment.

Conclusions:

  • Interim methadone services are effective and safe, offering comparable outcomes to standard treatment and improving access to OTPs.
  • Alternative strategies for facilitating medication access show promise and warrant further investigation.
  • Additional research is needed to compare alternative approaches against waitlist controls and to assess long-term patient outcomes.